Dr Bhawna Sirohi - Narayna Health  - Dr

Dr Bhawna Sirohi

Narayna Health

Dr

Bangalore , Karnataka | India

Main Specialties: Oncology

Additional Specialties: Medical Oncology

Dr Bhawna Sirohi - Narayna Health  - Dr

Dr Bhawna Sirohi

Introduction

Primary Affiliation: Narayna Health - Bangalore , Karnataka , India

Specialties:

Additional Specialties:


View Dr Bhawna Sirohi’s Resume / CV

Publications

45Publications

947Reads

-Profile Views

353PubMed Central Citations

Regorafenib in gastrointestinal stromal tumors.

Future Oncol 2014 ;10(9):1581-7

Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.101DOI Listing
April 2015
28 Reads
3 Citations
2.480 Impact Factor

Angelina's choice: private decision, public impact.

Indian J Med Ethics 2014 Jan-Mar;11(1):34-5

Breast Cancer Surgeon, Tata Memorial Centre, E Borges Marg, Parel, Mumbai 400 012 INDIA Rajendra Badwe e-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20529/IJME.2014.009DOI Listing
April 2015
58 Reads

Treatment of patients with advanced gastric cancer: experience from an Indian tertiary cancer center.

Med Oncol 2014 Oct 17;31(10):138. Epub 2014 Sep 17.

Department of Medical Oncology, Tata Memorial Centre (TMC), Mumbai, India,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-014-0138-xDOI Listing
October 2014
69 Reads
4 Citations
2.060 Impact Factor

Cell-type specificity of β-actin expression and its clinicopathological correlation in gastric adenocarcinoma.

World J Gastroenterol 2014 Sep;20(34):12202-11

Shafqat A Khan, Monica Tyagi, Ajit K Sharma, Sanjay Gupta, Epigenetics and Chromatin Biology Group, Cancer Research Institute, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, MH 410210, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i34.12202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161804PMC
September 2014
19 Reads
3 Citations
2.370 Impact Factor

Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT.

Eur J Nucl Med Mol Imaging 2014 Aug 27;41(8):1492-6. Epub 2014 May 27.

Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Jerbai Wadia Road, Parel, Mumbai, 400 012, India,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-014-2805-8DOI Listing
August 2014
39 Reads
7 Citations
5.383 Impact Factor

Cancer care delivery in India at the grassroot level: Improve outcomes.

Authors:
Bhawna Sirohi

Indian J Med Paediatr Oncol 2014 Jul;35(3):187-91

Department of Medical Oncology, Kiran Mazumdar-Shaw Cancer Centre, Narayana Health, Bengaluru, Karnataka, India. E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0971-5851.142030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202612PMC
July 2014
6 Reads
5 Citations

Chemotherapy and targeted therapy for gall bladder cancer.

Indian J Surg Oncol 2014 Jun 3;5(2):134-41. Epub 2014 Jun 3.

Department of GI & HPB Surgery, TMC, Tata Memorial Centre (TMC), Mumbai, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13193-014-0317-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116538PMC
June 2014
51 Reads
3 Citations

Clinical trials in India: At uncertain crossroads?

Indian J Med Paediatr Oncol 2014 Apr;35(2):133-5

Department of GI and HPB Surgery, Tata Memorial Centre, Mumbai, Maharashtra, India E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0971-5851.138947DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152628PMC
April 2014
33 Reads
3 Citations

Management of gastric cancer in Asia: resource-stratified guidelines.

Lancet Oncol 2013 Nov;14(12):e535-47

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S147020451370436
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(13)70436-4DOI Listing
November 2013
80 Reads
98 Citations
24.690 Impact Factor

Evolution of pancreatoduodenectomy in a tertiary cancer center in India: improved results from service reconfiguration.

Pancreatology 2013 Jan-Feb;13(1):63-71. Epub 2012 Nov 10.

Department of Gastrointestinal and Hepato-Pancreato-Biliary Surgical Oncology, Tata Memorial Hospital, Parel, Mumbai, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pan.2012.11.302DOI Listing
July 2013
35 Reads
11 Citations
2.504 Impact Factor

Cystic lesions of the pancreas: Improved understanding, diagnostics and refined outcomes.

South Asian J Cancer 2013 Jul;2(3):151-2

Department of GI and HPB Surgery, Tata Memorial Centre, Mumbai, Maharashtra, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2278-330X.114138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892509PMC
July 2013
33 Reads

Regorafenib: carving a niche in the crowded therapeutic landscape.

Expert Rev Anticancer Ther 2013 Apr;13(4):385-93

Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.13.12DOI Listing
April 2013
9 Reads
2.250 Impact Factor

Pancreatic neuroendocrine tumors.

Indian J Gastroenterol 2013 Jan 3;32(1):3-17. Epub 2012 Oct 3.

Gastrointestinal and Hepato-Pancreato-Biliary Surgical Oncology, Tata Memorial Centre, Ernest Borges Marg, Parel, Mumbai, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12664-012-0257-2DOI Listing
January 2013
11 Reads
1 Citation

New Delhi metallo-β-lactamase 1.

Authors:
Bhawna Sirohi

Lancet Infect Dis 2010 Nov;10(11):750; author reply 752-4

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S147330991070240
Publisher Site
http://dx.doi.org/10.1016/S1473-3099(10)70240-1DOI Listing
November 2010
8 Reads
1 Citation
22.433 Impact Factor

A phase 2 study of vatalanib in metastatic melanoma patients.

Eur J Cancer 2010 Oct 25;46(15):2671-3. Epub 2010 Aug 25.

Cambridge University Hospitals NHS Foundation Trust (Addenbrookes Hospital), Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.07.014DOI Listing
October 2010
39 Reads
5 Citations
5.420 Impact Factor

Cancer management in the twenty-first century in India.

Authors:
Bhawna Sirohi

Indian J Med Paediatr Oncol 2010 Apr;31(2):49-50

Department of Medical and Hemato-Oncology, EBMT Committee on Nuclear Accidents, Artemis Cancer Center, Artemis Health Sciences, Sector 51, Gurgaon, NCR, India E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0971-5851.71654DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970933PMC
April 2010
5 Reads

Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.

Endocr Relat Cancer 2010 Mar 29;17(1):R75-90. Epub 2010 Jan 29.

Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1677/ERC-09-0108DOI Listing
March 2010
6 Reads
8 Citations
4.805 Impact Factor

Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.

Expert Rev Anticancer Ther 2009 Nov;9(11):1583-98

Department of Oncology, Oncology Centre, Addenbrooke's Hospital, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.09.135DOI Listing
November 2009
7 Reads
11 Citations
2.250 Impact Factor

Lenalidomide in multiple myeloma.

Expert Rev Anticancer Ther 2009 Nov;9(11):1559-70

Hemato-Oncology, Parkside Oncology Clinic, Wimbledon, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.09.123DOI Listing
November 2009
26 Reads
3 Citations
2.250 Impact Factor

Ipsilateral breast tumor recurrence: is there any evidence for benefit of further systemic therapy?

Breast J 2009 May-Jun;15(3):268-78

Breast Unit, Royal Marsden NHS Foundation Trust, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2009.00716.xDOI Listing
October 2009
8 Reads
2 Citations
1.433 Impact Factor

Bevacizumab in the treatment of breast cancer.

Expert Rev Anticancer Ther 2008 Oct;8(10):1559-68

Addenbrookes Hospital, Hills Road, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.8.10.1559DOI Listing
October 2008
5 Reads
4 Citations
2.250 Impact Factor

Radiologic and nuclear events: the METREPOL severity of effect grading system.

Blood 2008 Jun;111(12):5757-8; author reply 5758-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-04-150243DOI Listing
June 2008
10 Reads
8 Citations
10.452 Impact Factor

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.

Breast Cancer Res 2007 ;9(5):112

Department of Medicine, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1763DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242654PMC
March 2008
13 Reads
10 Citations

Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival.

J Thorac Oncol 2007 Aug;2(8):735-40

Lung Unit, Royal Marsden NHS Foundation Trust, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31811f3a7dDOI Listing
August 2007
8 Reads
6 Citations
5.282 Impact Factor

Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy.

Hematology 2007 Apr;12(2):113-5

Haemato-Oncology Unit, Royal Marsden Hospital (RMH) and Institute of Cancer Research, Sutton, Surrey. UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10245330601111631DOI Listing
April 2007
4 Reads
1.190 Impact Factor

Stem cell transplantation in Hodgkin lymphoma.

Expert Rev Anticancer Ther 2007 Mar;7(3):297-306

Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.7.3.297DOI Listing
March 2007
7 Reads
1 Citation
2.250 Impact Factor

Epidemiology and outcomes research for MGUS, myeloma and amyloidosis.

Eur J Cancer 2006 Jul 25;42(11):1671-83. Epub 2006 Jul 25.

Royal Marsden NHS Trust and Parkside Cancer Centre, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2006.01.065DOI Listing
July 2006
7 Reads
11 Citations
5.420 Impact Factor

Localized COSY and DQF-COSY 1H-MRS sequences for investigating human tibial bone marrow in vivo and initial application to patients with acute leukemia.

J Magn Reson Imaging 2005 Oct;22(4):541-8

Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.20413DOI Listing
October 2005
5 Reads
3 Citations
3.210 Impact Factor

Haemopoietic progenitor cell transplantation in patients with previous history of invasive fungal infection.

Leuk Lymphoma 2005 Aug;46(8):1143-50

Department of Paediatric Haematology and Oncology, The Royal Marsden Hospital, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190500097052DOI Listing
August 2005
7 Reads
3 Citations

The impact on resources of prevalence and nature of skin problems in a modern intensive haemato-oncology practice.

Hematology 2004 Oct-Dec;9(5-6):415-23

Royal Marsden NHS Trust and Institute of Cancer Research, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10245330412331269867DOI Listing
April 2005
10 Reads
2 Citations
1.190 Impact Factor

Multiple myeloma.

Lancet 2004 Mar;363(9412):875-87

Institute of Cancer Research and Royal Marsden NHS Trust, Downs Road, Sutton, Surrey SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(04)15736-XDOI Listing
March 2004
5 Reads
26 Citations
45.220 Impact Factor

Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A.

Haematologica 2003 May;88(5):529-37

Academic Department of Haematology and Cytogenetics, The Institute of Cancer Research and Royal Marsden Hospital Trust, 203 Fulham Road, London SW3 6JJ, UK.

View Article

Download full-text PDF

Source
May 2003
4 Reads
11 Citations
5.870 Impact Factor

Top co-authors

Ray Powles
Ray Powles

2 Cancer Centre London

14
Shailesh V Shrikhande
Shailesh V Shrikhande

Tata Memorial Hospital

11
Jennifer Treleaven
Jennifer Treleaven

The Institute of Cancer Research

6
Jayesh Mehta
Jayesh Mehta

The Feinberg School of Medicine

4
Seema Singhal
Seema Singhal

All India Institute of Medical Sciences

4
Samar Kulkarni
Samar Kulkarni

The Christie NHS Foundation Trust

4
Dietger Niederwieser
Dietger Niederwieser

University of Leipzig

3
Bristi Basu
Bristi Basu

Cambridge University Hospitals NHS Foundation Trust

3